Literature DB >> 3220623

The alteration in the pattern of pulmonary metastasis with adjuvant chemotherapy in osteosarcoma.

H Yamaguchi1, T Nojima, T Yagi, T Matsuno, T Sasaki, K Isu, Y Ubayama, S Yamawaki, M Gotch.   

Abstract

Alterations in the pattern of pulmonary metastasis of patients with osteosarcoma treated with adjuvant chemotherapy were studied. Thirty two patients who were treated with both radical surgery and adjuvant chemotherapy were observed (chemotherapy group). As a control, sixty two patients treated with radical surgery alone were also assessed (non-chemotherapy group). The chemotherapy group demonstrated a reduction in the number and a delay in the appearance of metastases. The tumour doubling time did not differ between the chemotherapy and non-chemotherapy groups. The initial site of metastasis among the chemotherapy group was most commonly in the lower lung field, whereas among the non-chemotherapy group it was usually to the middle lung field. The chemotherapy group survived longer than the non-chemotherapy group after developing pulmonary metastases. Histological examination showed that the metastatic foci stimulated the primary sites.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3220623     DOI: 10.1007/bf00317829

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  11 in total

1.  Maximum utilization of the life table method in analyzing survival.

Authors:  S J CUTLER; F EDERER
Journal:  J Chronic Dis       Date:  1958-12

2.  Observations on growth rates of human tumors.

Authors:  V P COLLINS; R K LOEFFLER; H TIVEY
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1956-11

3.  Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.

Authors:  N Jaffe; E Frei; D Traggis; Y Bishop
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

4.  High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.

Authors:  G Rosen; S Suwansirikul; C Kwon; C Tan; S J Wu; E J Beattie; M L Murphy
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

5.  Amputation and adriamycin in primary osteosarcoma.

Authors:  E P Cortes; J F Holland; J J Wang; L F Sinks; J Blom; H Senn; A Bank; O Glidewell
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

6.  Osteogenic sarcoma: alterations in the pattern of pulmonary metastases with adjuvant chemotherapy.

Authors:  N Jaffe; E Smith; H T Abelson; E Frei
Journal:  J Clin Oncol       Date:  1983-04       Impact factor: 44.544

7.  Changing indications for bone scintigraphy in patients with osteosarcoma.

Authors:  H Goldstein; B J McNeil; E Zufall; N Jaffe; S Treves
Journal:  Radiology       Date:  1980-04       Impact factor: 11.105

8.  Differing determinants of prognosis following resection of pulmonary metastases from osteogenic and soft tissue sarcoma patients.

Authors:  J A Roth; J B Putnam; M N Wesley; S A Rosenberg
Journal:  Cancer       Date:  1985-03-15       Impact factor: 6.860

9.  Improved survival in children with osteosarcoma following resection of pulmonary metastases.

Authors:  R T Schaller; J Haas; J Schaller; A Morgan; A Bleyer
Journal:  J Pediatr Surg       Date:  1982-10       Impact factor: 2.545

10.  Changing metastatic patterns of osteosarcoma.

Authors:  A E Giuliano; S Feig; F R Eilber
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

View more
  1 in total

1.  VEGF silencing inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via PI3K/AKT signaling pathway.

Authors:  Jian Zhao; Zi-Ru Zhang; Na Zhao; Bao-An Ma; Qing-Yu Fan
Journal:  Int J Clin Exp Med       Date:  2015-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.